MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: Jul 23, 2024 · CIK: 1878313
| Field | Detail |
|---|---|
| Company | Maia Biotechnology, INC. (MAIA) |
| Form Type | 8-K |
| Filed Date | Jul 23, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
MAIA Bio filed an 8-K. Check for updates.
AI Summary
MAIA Biotechnology, Inc. filed an 8-K on July 23, 2024, to report other events and financial statements. The filing does not contain specific details about the nature of these events or financial figures within the provided text.
Why It Matters
This filing indicates that MAIA Biotechnology, Inc. has submitted a current report to the SEC, which may contain material updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural report without immediate disclosed financial or operational impacts.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- July 23, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41455 (identifier) — Commission File Number
- 444 West Lake Street, Suite 1700 Chicago, IL 60606 (address) — Principal executive offices
FAQ
What specific events are being reported in this 8-K filing?
The provided text indicates the filing is for 'Other Events' and 'Financial Statements and Exhibits', but does not detail the specific nature of these events.
When was this 8-K report filed?
The report was filed on July 23, 2024.
What is the principal executive office address for MAIA Biotechnology, Inc.?
The principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What is MAIA Biotechnology, Inc.'s Commission File Number?
MAIA Biotechnology, Inc.'s Commission File Number is 001-41455.
What is the state of incorporation for MAIA Biotechnology, Inc.?
MAIA Biotechnology, Inc. is incorporated in Delaware.
Filing Stats: 774 words · 3 min read · ~3 pages · Grade level 14 · Accepted 2024-07-23 17:05:10
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 20KB
- 0001493152-24-028828.txt ( ) — 238KB
- maia-20240723.xsd (EX-101.SCH) — 3KB
- maia-20240723_lab.xml (EX-101.LAB) — 33KB
- maia-20240723_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: July 23, 2024 MAIA BIOTECHNOLOGY, INC. By: /s/ Vlad Vitoc Name: Vlad Vitoc Title: Chief Executive Officer 3